UV Detection in Peptide HPLC
Ultraviolet detection is widely used in peptide chromatography because peptide bonds and aromatic side chains absorb UV light.
Low-wavelength detection
The peptide backbone absorbs strongly in the low-UV region. This provides broad sensitivity across many sequences but can also increase interference from solvents, additives, and baseline drift.
Aromatic-residue detection
Tryptophan, tyrosine, and phenylalanine absorb at higher wavelengths. Detection at these wavelengths can reduce background but may produce weak response for peptides lacking aromatic residues.
Wavelength selection
Wavelength selection should reflect:
- peptide sequence
- expected impurities
- mobile-phase absorbance
- detector sensitivity
- required quantitation range
- compatibility with reference standards
Response factors
Different impurities may have different molar absorptivity. Therefore, equal UV area does not necessarily mean equal mass.
This is especially important when a degradation product loses or gains an aromatic chromophore.
Diode-array detection
A diode-array detector records absorbance across multiple wavelengths. This can support spectral comparison and peak-purity analysis, but similar spectra can limit discrimination.
Frequently asked questions
Why is 214 nm common?
Peptide bonds absorb strongly in the low-UV region, making this wavelength useful for broad detection.
Is 280 nm always better?
No. It is most useful for peptides containing aromatic residues.
Can UV detection identify a peptide?
Not by itself. Retention and absorbance support characterization, but identity usually requires orthogonal evidence.
Why can area percent change with wavelength?
Different components may absorb differently at different wavelengths.
Key takeaways
UV detection is simple and powerful, but response depends on sequence, wavelength, solvent, and impurity structure. Purity values are meaningful only within the context of the selected detection conditions.
References
- ICH Q2(R2). Validation of Analytical Procedures.
- ICH Q14. Analytical Procedure Development.
- FDA. Analytical Procedures and Methods Validation for Drugs and Biologics.
TSMS Labs educational disclaimer: For laboratory research and educational purposes only. Not for human consumption. This content is not medical, clinical, or regulatory advice.